 | | PRD_000754 | | Name: | PSEUDO-IODOTYROSTATIN | | Formula: | C23 H27 I N2 O4 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000755 | | Name: | BOC ALA ALA PRO PVA | | Formula: | C20 H37 N4 O8 P | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000756 | | Name: | N-(3-carboxypropanoyl)-L-valyl-N-[(1R)-5-amino-1-phosphonopentyl]-L-prolinamide | | Formula: | C19 H35 N4 O8 P | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000762 | | Name: | METHANOBACTIN MB-OB3B | | Formula: | C45 H56 Cu N10 O16 S5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000764 | | Name: | CYCLOSPORIN D, 5,7 mutation | | Formula: | C64 H117 N11 O12 S | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED IN DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL).
THE CYCLOSPORIN D MOLECULE WAS MODIFIED AT
POSITIONS 5 AND 7 TO BE
(6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N-DIMETHYL-THREONINE AND
(2-S-METHYL)-SARCOSINE, RESPECTIVELY. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000765 | | Name: | CYCLOSPORIN A, 5 mutation | | Formula: | C63 H113 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN WAS MODIFIED AT POSITION 5 TO BE
4-[(E)-2-BUTENYL]-4,4,N-TRIMETHYL-L-THREONINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000766 | | Name: | CYCLOSPORIN A, 6 mutation | | Formula: | C63 H113 N11 O13 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 6 TO BE 2-AMINO-5-HYDROXYPENTANOIC ACID | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000767 | | Name: | CYCLOSPORIN A, 7 mutation | | Formula: | C63 H113 N11 O13 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A WAS MODIFIED AT POSITION 7
TO BE N-METHYL-D-SERINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000768 | | Name: | CYCLOSPORIN A, 8 mutation | | Formula: | C62 H111 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 8 TO BE N-METHYL-ISOLEUCINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000769 | | Name: | 2-{(3S)-3-[(benzylsulfonyl)amino]-2-oxopiperidin-1-yl}-N-{(2S)-1-[(3S)-1-carbamimidoylpiperidin-3-yl]-3-oxopropan-2-yl}acetamide | | Formula: | C23 H34 N6 O5 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_002426 | | Name: | Corramycin | | Formula: | C51 H81 N11 O21 | | Definition date: | 2023-08-16 | | Last modified: | 2023-08-16 |
|
 | | PRD_002432 | | Name: | Pam3-SKKKK | | Formula: | C81 H160 N10 O13 S | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-12 |
|
 | | PRD_002528 | | Name: | 142D6 | | Formula: | C26 H37 F N4 O6 S | | Description: | Lys-covalent pan-IAP inhibitor | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-12 |
|
 | | PRD_002527 | | Name: | Intermediate for maxamycins synthesis | | Formula: | C84 H114 Cl2 N8 O17 S Si2 | | Definition date: | 2023-07-05 | | Last modified: | 2023-07-05 |
|
 | | PRD_002268 | | Name: | Lipid II | | Formula: | C54 H91 N8 O26 P2 | | Definition date: | 2020-08-19 | | Last modified: | 2023-06-11 |
|
 | | PRD_002441 | | Name: | Myxovalargin B | | Formula: | C80 H136 N21 O17 | | Definition date: | 2023-01-25 | | Last modified: | 2023-05-11 |
|
 | | PRD_002442 | | Name: | Myxovalargin A | | Formula: | C81 H138 N21 O17 | | Definition date: | 2023-01-18 | | Last modified: | 2023-05-11 |
|
 | | PRD_002419 | | Name: | Cyclomarin A | | Formula: | C56 H82 N8 O11 | | Definition date: | 2023-03-29 | | Last modified: | 2023-03-29 |
|
 | | PRD_002425 | | Name: | Drosocin | | Formula: | C98 H166 N34 O24 | | Definition date: | 2023-03-08 | | Last modified: | 2023-03-08 |
|
 | | PRD_002526 | | Name: | DFFR-chloromethyl ketone inhibitor | | Formula: | C25 H34 N6 O3 | | Definition date: | 2023-02-22 | | Last modified: | 2023-02-22 |
|
 | | PRD_002512 | | Name: | all-D Helicon Polypeptide FP40914 | | Formula: | C92 H114 N20 O22 S2 | | Definition date: | 2023-02-15 | | Last modified: | 2023-02-15 |
|
 | | PRD_002513 | | Name: | all-D Helicon Polypeptide FP40926 | | Formula: | C86 H116 N22 O24 S3 | | Definition date: | 2023-02-15 | | Last modified: | 2023-02-15 |
|
 | | PRD_002514 | | Name: | an all-D Helicon Polypeptide FP40927 | | Formula: | C81 H122 N19 O21 S2 | | Definition date: | 2023-02-15 | | Last modified: | 2023-02-15 |
|
 | | PRD_002515 | | Name: | all-D Helicon Polypeptide FP40918 | | Formula: | C84 H115 N22 O26 S2 | | Definition date: | 2023-02-15 | | Last modified: | 2023-02-15 |
|
 | | PRD_002424 | | Name: | Darobactin 22 | | Formula: | C53 H67 N15 O11 | | Definition date: | 2023-01-11 | | Last modified: | 2023-01-11 |
|
